Literature DB >> 10566639

Body composition determined by six different methods in women bilaterally adrenalectomized for treatment of Cushing's disease.

S A Kemink1, J T Frijns, A R Hermus, G F Pieters, A G Smals, W D van Marken Lichtenbelt.   

Abstract

In 14 women, aged 47.2 +/- 10.5 yr, bilaterally adrenalectomized for Cushing's disease 13.6 +/- 7.7 yr before, all receiving conventional doses of glucocorticoid and mineralocorticoid substitution, body composition was studied with regard to body fat, body fat distribution, fat-free mass, and bone mineral density. The data were compared with those of 14 healthy women of similar age, body mass index, and menopausal state. Five different body composition measurement methods were compared, i.e. body densitometry by underwater weighing (UWW), total body water measurement by deuterium dilution (D2O dilution), dual energy x-ray absorptiometry (DXA), bioelectrical impedance spectrometry (BIS), and skinfold measurements, using a four-component model (4C-model) as the reference method. In the patients the percent body fat was significantly higher than that in the controls as determined by all methods, whereas fat-free mass was significantly lower when measured with the 4C-model, UWW, D2O dilution, DXA, or BIS. Measured by DXA, the percent trunk fat, estimated as [fat mass of the trunk (g)/total fat mass (g)] x 100%, was significantly higher in the patients than in the controls (39.3 +/- 6.4% and 29.9 +/- 7.8%, respectively; P < 0.001). Measured by DXA, there was no difference in total bone mineral density between the groups. Differences between the 4C-model, UWW, D2O dilution, and DXA for determination of percent body fat were rather small. Skinfold measurements and BIS results, however, deviated substantially from those obtained using the 4C-model. The study indicates that adrenalectomized patients receiving conventional glucocorticoid substitution have increased body fat percentages with a centripetal fat distribution and lowered fat-free mass, but normal bone mineral density. Furthermore, the study indicates that for clinical practice, DXA, D2O dilution, UWW, and the 4C-model can be used for determination of body composition in this patient group, whereas the more convenient bedside methods, BIS and skinfold measurements, did not give reliable results. We suppose that glucocorticoid overreplacement in adrenalectomized patients might be the cause of their abnormal body composition, although GH deficiency after pituitary surgery could have played a contributory role in some of the patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10566639     DOI: 10.1210/jcem.84.11.6143

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Body composition and vertebral fracture risk in female patients treated with glucocorticoid.

Authors:  H Kaji; T Tobimatsu; J Naito; M-F Iu; M Yamauchi; T Sugimoto; K Chihara
Journal:  Osteoporos Int       Date:  2005-12-31       Impact factor: 4.507

Review 2.  Diagnostic work-up in steroid myopathy.

Authors:  Marco Alessandro Minetto; Valentina D'Angelo; Emanuela Arvat; Santosh Kesari
Journal:  Endocrine       Date:  2017-11-15       Impact factor: 3.633

3.  Severe fatigue in patients with adrenal insufficiency: physical, psychosocial and endocrine determinants.

Authors:  V Giebels; H Repping-Wuts; G Bleijenberg; J M Kroese; N Stikkelbroeck; A Hermus
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

4.  Anthropometric measures and fasting insulin levels in children before and after cure of Cushing syndrome.

Authors:  Margaret F Keil; Jennifer Graf; Nirmal Gokarn; Constantine A Stratakis
Journal:  Clin Nutr       Date:  2011-12-07       Impact factor: 7.324

5.  MRI assessment of lean and adipose tissue distribution in female patients with Cushing's disease.

Authors:  Eliza B Geer; Wei Shen; Dympna Gallagher; Mark Punyanitya; Helen C Looker; Kalmon D Post; Pamela U Freda
Journal:  Clin Endocrinol (Oxf)       Date:  2010-10       Impact factor: 3.478

Review 6.  Clinical consequences of Cushing's syndrome.

Authors:  Elena Valassi; Iris Crespo; Alicia Santos; Susan M Webb
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

7.  Ultrasound-based detection of glucocorticoid-induced impairments of muscle mass and structure in Cushing's disease.

Authors:  M A Minetto; C Caresio; M Salvi; V D'Angelo; N E Gorji; F Molinari; G Arnaldi; S Kesari; E Arvat
Journal:  J Endocrinol Invest       Date:  2018-11-15       Impact factor: 4.256

8.  Bone mineral density, bone turnover markers, lean mass, and fat mass in Egyptian children with congenital adrenal hyperplasia.

Authors:  Soha M Abd El Dayem; Ghada M Anwar; Hassan Salama; Ashraf F Kamel; Nahed Emara
Journal:  Arch Med Sci       Date:  2010-03-09       Impact factor: 3.318

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.